In this work, we establish a general theoretical framework to determine the rates governing tau accumulation and apply it to measurements of seed and aggregate concentrations in AD brains to determine the rate-limiting process and calculate the associated reaction rates. The gene discussed is MAPT; the disease is Alzheimer disease.